1. Home
  2. TER vs NTRA Comparison

TER vs NTRA Comparison

Compare TER & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teradyne Inc.

TER

Teradyne Inc.

HOLD

Current Price

$195.58

Market Cap

28.7B

Sector

Industrials

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$231.37

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TER
NTRA
Founded
1960
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
27.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TER
NTRA
Price
$195.58
$231.37
Analyst Decision
Buy
Strong Buy
Analyst Count
14
15
Target Price
$168.15
$235.87
AVG Volume (30 Days)
3.3M
1.5M
Earning Date
01-28-2026
11-06-2025
Dividend Yield
0.25%
N/A
EPS Growth
N/A
N/A
EPS
2.75
N/A
Revenue
$2,859,571,000.00
$2,116,676,000.00
Revenue This Year
$9.79
$32.77
Revenue Next Year
$22.74
$16.51
P/E Ratio
$69.16
N/A
Revenue Growth
4.46
38.17
52 Week Low
$65.77
$125.38
52 Week High
$205.00
$246.90

Technical Indicators

Market Signals
Indicator
TER
NTRA
Relative Strength Index (RSI) 58.09 58.66
Support Level $182.16 $221.84
Resistance Level $204.70 $232.76
Average True Range (ATR) 6.63 6.27
MACD -1.59 -2.72
Stochastic Oscillator 55.17 39.90

Price Performance

Historical Comparison
TER
NTRA

About TER Teradyne Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: